Trademark: 87214828
Word
ERMEZA
Status
Dead
Status Code
606
Status Date
Monday, November 4, 2019
Serial Number
87214828
Mark Type
4000
Filing Date
Tuesday, October 25, 2016
Published for Opposition
Tuesday, January 31, 2017
Abandoned Date
Monday, November 4, 2019

Trademark Owner History
Mylan Pharmaceuticals, Inc. - Owner At Publication

Classifications
5 Hormone replacement therapy transdermals

Trademark Events
Nov 4, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
Nov 4, 2019
Abandonment - No Use Statement Filed
Apr 16, 2019
Notice Of Approval Of Extension Request E-Mailed
Apr 15, 2019
Extension 4 Granted
Mar 28, 2019
Extension 4 Filed
Apr 10, 2019
Notice Of Revival - E-Mailed
Apr 10, 2019
Extension Received With Teas Petition
Apr 10, 2019
Petition To Revive-Granted
Apr 10, 2019
Teas Petition To Revive Received
Jan 18, 2019
Notice Of Approval Of Extension Request E-Mailed
Jan 17, 2019
Extension 3 Granted
Sep 28, 2018
Extension 3 Filed
Jan 17, 2019
Case Assigned To Intent To Use Paralegal
Nov 1, 2018
Notice Of Revival - E-Mailed
Nov 1, 2018
Extension Received With Teas Petition
Nov 1, 2018
Petition To Revive-Granted
Nov 1, 2018
Teas Petition To Revive Received
Oct 29, 2018
Abandonment Notice Mailed - No Use Statement Filed
Oct 29, 2018
Abandonment - No Use Statement Filed
Mar 17, 2018
Notice Of Approval Of Extension Request E-Mailed
Mar 15, 2018
Extension 2 Granted
Mar 15, 2018
Extension 2 Filed
Mar 15, 2018
Teas Extension Received
Sep 15, 2017
Notice Of Approval Of Extension Request E-Mailed
Sep 13, 2017
Extension 1 Granted
Sep 13, 2017
Extension 1 Filed
Sep 13, 2017
Teas Extension Received
Mar 28, 2017
Noa E-Mailed - Sou Required From Applicant
Jan 31, 2017
Official Gazette Publication Confirmation E-Mailed
Jan 31, 2017
Published For Opposition
Jan 11, 2017
Notification Of Notice Of Publication E-Mailed
Dec 23, 2016
Approved For Pub - Principal Register
Dec 23, 2016
Assigned To Examiner
Oct 28, 2016
New Application Office Supplied Data Entered In Tram
Oct 28, 2016
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24